Actuate Therapeutics, Inc. · NASDAQ:ACTU

Schmitt Daniel M exercised options for 272,056 Actuate Therapeutics, Inc. shares (Form 4)

Traded Aug 14, 2026 · Filed Aug 14, 2026

On Aug 14, 2026, Schmitt Daniel M (Director, President, CEO and Director) exercised options for 272,056 Actuate Therapeutics, Inc. shares, leaving 301,716 shares. Filed Aug 14, 2026 (Form 4).

Options exercised
272,056 shares
Holding after
301,716 shares
Trading plan
No
Role
Director, President, CEO and Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 14, 2026Common StockOption exercise272,056422,237Direct
Aug 14, 2026Common StockShares withheld for tax120,521US$1.01301,716Direct

Source

View original at SEC

Related